Glenmark settles patent litigation with Daiichi, Genzyme - Yahoo! India Finance

New Delhi, July 4 (PTI) Glenmark Pharmaceuticals today said it has settled a patent infringement litigation with Daiichi Sankyo and Genzyme paving way for it to market generic Colesevelam Hydrochloride used for treating diabetes and high cholesterol in the US market. As per the terms of the settlement, the company has received a licence from Daiichi Sankyo...